Marco Dellabella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marco Dellabella has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Daniele Castellani
Department of Medicine and Surgery, Libera Università Mediterranea (LUM) University “Giuseppe Degennaro”, Casamassima, Italy
14 shared publications Giulio Milanese
Department of Clinic and Specialistic Sciences, Urology, Polytechnic University of the Marches Region, A.O. Ospedali Riuniti Ancona.
10 shared publicationsGiovanni Muzzonigro
Department of Clinic and Specialistic Sciences, Urology, Polytechnic University of the Marches Region, A.O. Ospedali Riuniti Ancona
9 shared publicationsLuca Gasparri
Department of Urology, IRCCS-INRCA, Ancona, Italy
7 shared publications- Giacomo Maria Pirola
Urology Department, San Giuseppe Hospital, IRCCS Multimedica, Multimedica Group, Milan, Italy
5 shared publications Alessandro Branchi
Department of Urology, IRCCS-INRCA, Ancona, Italy
4 shared publications
Latest Publications
- 19 August 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (8) , 1676-1688
Incidence of Overactive Bladder Symptoms and Dysuria Following Transurethral Interventions for Benign Prostatic Enlargement: A Systematic Review and Meta‐Analysis of Comparative and Randomized Studies
Introduction: Some patients report persistent/recurrent lower urinary tract symptoms (LUTS) after benign prostatic enlargement (BPE) surgery. This study aims to systematically assess the incidence of storage symptoms and dysuria after transurethral treatment of BPE in randomized studies comparing transurethral resection of the prostate (TURP) versus Enucleation versus Ablation procedures. Methods: This study adhered to the 2020 PRISMA framework. A broad literature search was performed in January 2025, using Embase, PUBMED, and Scopus using a combination of Medical Subject terms and keywords. Only English and randomized studies were accepted. Incidence of postoperative LUTS (storage symptoms and dysuria) was sorted in early (up to 3 months), and persistent (> 3 months) and assessed using the Cochran–Mantel–Haenszel Method with the random effect model and reported as odds ratio (OR), 95% confidence interval (CI), and p values. OR > 1 indicates that TURP decreases the odds of postoperative LUTS. Results: A total of 35 studies were accepted (546 patients in Enucleation, 1678 in Ablation, and 1702 in TURP). Incidence of early postoperative LUTS favors the TURP group compared with Ablation (OR 1.72). Subanalysis demonstrates no difference between monopolar (M)‐TURP and Ablation but LUTS favors bipolar (B)‐TURP (OR 10.69). Early postoperative LUTS favors the TURP compared with Enucleation (OR 1.71). Persistent postoperative LUTS favors the TURP group compared with Ablation (OR 2.75). Early postoperative storage symptoms favor B‐TURP over Ablation (OR 4.00) and Enucleation (OR 1.71). Late postoperative storage symptoms favor TURP over Ablation (OR 2.13). Early postoperative dysuria was similar between TURP versus Enucleation and versus Ablation. Persistent postoperative dysuria favors M‐TURP compared with Ablation (OR 6.92). Conclusion: TURP is associated with a lower odds of early and persistent LUTS compared to Ablation and Enucleation and is a valuable option particularly when minimizing postoperative LUTS is a priority.
- 19 August 2025
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (8) , 1676-1688
Incidence of Overactive Bladder Symptoms and Dysuria Following Transurethral Interventions for Benign Prostatic Enlargement: A Systematic Review and Meta‐Analysis of Comparative and Randomized Studies
Introduction: Some patients report persistent/recurrent lower urinary tract symptoms (LUTS) after benign prostatic enlargement (BPE) surgery. This study aims to systematically assess the incidence of storage symptoms and dysuria after transurethral treatment of BPE in randomized studies comparing transurethral resection of the prostate (TURP) versus Enucleation versus Ablation procedures. Methods: This study adhered to the 2020 PRISMA framework. A broad literature search was performed in January 2025, using Embase, PUBMED, and Scopus using a combination of Medical Subject terms and keywords. Only English and randomized studies were accepted. Incidence of postoperative LUTS (storage symptoms and dysuria) was sorted in early (up to 3 months), and persistent (> 3 months) and assessed using the Cochran–Mantel–Haenszel Method with the random effect model and reported as odds ratio (OR), 95% confidence interval (CI), and p values. OR > 1 indicates that TURP decreases the odds of postoperative LUTS. Results: A total of 35 studies were accepted (546 patients in Enucleation, 1678 in Ablation, and 1702 in TURP). Incidence of early postoperative LUTS favors the TURP group compared with Ablation (OR 1.72). Subanalysis demonstrates no difference between monopolar (M)‐TURP and Ablation but LUTS favors bipolar (B)‐TURP (OR 10.69). Early postoperative LUTS favors the TURP compared with Enucleation (OR 1.71). Persistent postoperative LUTS favors the TURP group compared with Ablation (OR 2.75). Early postoperative storage symptoms favor B‐TURP over Ablation (OR 4.00) and Enucleation (OR 1.71). Late postoperative storage symptoms favor TURP over Ablation (OR 2.13). Early postoperative dysuria was similar between TURP versus Enucleation and versus Ablation. Persistent postoperative dysuria favors M‐TURP compared with Ablation (OR 6.92). Conclusion: TURP is associated with a lower odds of early and persistent LUTS compared to Ablation and Enucleation and is a valuable option particularly when minimizing postoperative LUTS is a priority.
- 1 May 2021
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 87 (5) , 621-622
Continuous spinal infusion of prilocaine in high-risk surgical patients: a reply
Article: Continuous spinal infusion of prilocaine in high-risk surgical patients: a reply - Minerva Anestesiologica 2021 May;87(5):621-2 - Minerva Medica - Journals
- 1 May 2021
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 87 (5) , 621-622
Continuous spinal infusion of prilocaine in high-risk surgical patients: a reply
Article: Continuous spinal infusion of prilocaine in high-risk surgical patients: a reply - Minerva Anestesiologica 2021 May;87(5):621-2 - Minerva Medica - Journals
- 28 April 2021
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 33 (6) , 1757-1763
Comparison between thulium laser vapoenucleation and plasmakinetic resection of the prostate in men aged 75 years and older in a real-life setting: a propensity score analysis
Background Urologists may hesitate to offer transurethral resection of the prostate (TURP) because of increased morbidity in elderly patients. Aims We aimed to compare data on postoperative outcomes of elderly men undergoing bipolar transurethral resection of the prostate (B-TURP) as compared to thulium laser vapoenucleation of the prostate (ThuVEP). Methods We retrospectively reviewed data of all patients aged ≥ 75 years who underwent benign prostatic hyperplasia surgery. Differences between interventions were estimated using propensity scores (PS) to adjust for different patients characteristics. Results Between 2017 and 2020, 275 men were included in the analysis. Propensity score retrieved 65 patients in each group. Median age was 78 (4) years in B-TURP group and 78 (6) in ThuVEP group. Median prostate volume was 63 (35) ml and 54 (24) ml in B-TURP group and ThuVEP group, respectively. Only American Society of Anesthesiologists score was significantly higher in ThuVEP group (p = 0.006). Median operation time, catheterization time, and hospital stay were similar in both groups (55 min, 2 and 3 days). Overall, 84.6% of men had no complications, with no significant differences between the groups (p = 0.234). Only one patient in B-TURP group experienced a Clavien grade IIIb complication. By 1 year, there were a statistically significant differences in International Prostate Symptom Score (p = 0.000) in favor of B-TURP group and in maximal urine flow rate (p = 0.000) in favor of ThuVEP group. Discussion and conclusions Both procedures showed excellent functional improvements one year after surgery with a low rate of major complications in men aged ≥ 75 years with small-to-medium sized prostates.
- 28 April 2021
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 33 (6) , 1757-1763
Comparison between thulium laser vapoenucleation and plasmakinetic resection of the prostate in men aged 75 years and older in a real-life setting: a propensity score analysis
Background Urologists may hesitate to offer transurethral resection of the prostate (TURP) because of increased morbidity in elderly patients. Aims We aimed to compare data on postoperative outcomes of elderly men undergoing bipolar transurethral resection of the prostate (B-TURP) as compared to thulium laser vapoenucleation of the prostate (ThuVEP). Methods We retrospectively reviewed data of all patients aged ≥ 75 years who underwent benign prostatic hyperplasia surgery. Differences between interventions were estimated using propensity scores (PS) to adjust for different patients characteristics. Results Between 2017 and 2020, 275 men were included in the analysis. Propensity score retrieved 65 patients in each group. Median age was 78 (4) years in B-TURP group and 78 (6) in ThuVEP group. Median prostate volume was 63 (35) ml and 54 (24) ml in B-TURP group and ThuVEP group, respectively. Only American Society of Anesthesiologists score was significantly higher in ThuVEP group (p = 0.006). Median operation time, catheterization time, and hospital stay were similar in both groups (55 min, 2 and 3 days). Overall, 84.6% of men had no complications, with no significant differences between the groups (p = 0.234). Only one patient in B-TURP group experienced a Clavien grade IIIb complication. By 1 year, there were a statistically significant differences in International Prostate Symptom Score (p = 0.000) in favor of B-TURP group and in maximal urine flow rate (p = 0.000) in favor of ThuVEP group. Discussion and conclusions Both procedures showed excellent functional improvements one year after surgery with a low rate of major complications in men aged ≥ 75 years with small-to-medium sized prostates.
- 25 March 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (4) , 1049-1062
What urologists need to know about ketamine‐induced uropathy: A systematic review
Aims: Ketamine is a general anesthetic. Dissociative effects and low cost led ketamine becoming an illegal recreational drug in young adults. Ketamine‐induced uropathy (KIU) is one of the complications observed in abusers. This study aimed to provide a systematic literature review on KIU clinical presentation, pathophysiology, and treatments.Methods: We performed the literature search in PubMed, Web of Science, Scopus, and Embase using the terms ketamine and bladder. English papers on human and animal studies were accepted.Results: A total of 75 papers were selected. Regular ketamine users complain about severe storage symptoms and pelvic pain. Hydronephrosis may develop in long‐term abusers and is correlated to the contracted bladder, ureteral stenosis, or vesicoureteral reflux due to ureteral involvement and/or bladder fibrosis. Cystoscopy shows ulcerative cystitis. Ketamine in urine might exert direct toxicity to the urothelium, disrupting its barrier function and enhancing cell apoptosis. The presence of ketamine/ions in the bladder wall result in neurogenic/IgE‐mediated inflammation, stimulation of the inducible nitric oxide synthase‐cytokines‐cyclooxygenase pathway with persistent inflammation and fibrosis. Abstinence is the first therapeutic step. Anti‐inflammatory drugs, analgesics and anticholinergics, intravesical instillation of hyaluronic acid, hydrodistension and intravesical injection of botulin toxin‐A were helpful in patients with early‐stage KIU. In patients with end‐stage disease, the control of intractable symptoms and the increase of bladder capacity were the main recommendations to perform augmentation enterocystoplasty.Conclusions: KIU is becoming a worldwide health concern, which should be taken into account in the differential diagnosis of ulcerative cystitis.
- 25 March 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (4) , 1049-1062
What urologists need to know about ketamine‐induced uropathy: A systematic review
Aims: Ketamine is a general anesthetic. Dissociative effects and low cost led ketamine becoming an illegal recreational drug in young adults. Ketamine‐induced uropathy (KIU) is one of the complications observed in abusers. This study aimed to provide a systematic literature review on KIU clinical presentation, pathophysiology, and treatments.Methods: We performed the literature search in PubMed, Web of Science, Scopus, and Embase using the terms ketamine and bladder. English papers on human and animal studies were accepted.Results: A total of 75 papers were selected. Regular ketamine users complain about severe storage symptoms and pelvic pain. Hydronephrosis may develop in long‐term abusers and is correlated to the contracted bladder, ureteral stenosis, or vesicoureteral reflux due to ureteral involvement and/or bladder fibrosis. Cystoscopy shows ulcerative cystitis. Ketamine in urine might exert direct toxicity to the urothelium, disrupting its barrier function and enhancing cell apoptosis. The presence of ketamine/ions in the bladder wall result in neurogenic/IgE‐mediated inflammation, stimulation of the inducible nitric oxide synthase‐cytokines‐cyclooxygenase pathway with persistent inflammation and fibrosis. Abstinence is the first therapeutic step. Anti‐inflammatory drugs, analgesics and anticholinergics, intravesical instillation of hyaluronic acid, hydrodistension and intravesical injection of botulin toxin‐A were helpful in patients with early‐stage KIU. In patients with end‐stage disease, the control of intractable symptoms and the increase of bladder capacity were the main recommendations to perform augmentation enterocystoplasty.Conclusions: KIU is becoming a worldwide health concern, which should be taken into account in the differential diagnosis of ulcerative cystitis.
- 1 October 2019
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 17 (5) , 402-407
Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index
- 1 October 2019
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 17 (5) , 402-407
Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index
- 20 September 2019
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 43 (8) , 431-438
Elastic fusion biopsy versus systematic biopsy for prostate cancer detection: Results of a multicentric study on 1119 patients
- 20 September 2019
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 43 (8) , 431-438
Elastic fusion biopsy versus systematic biopsy for prostate cancer detection: Results of a multicentric study on 1119 patients
- Open Access
- 1 August 2019
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 45 (4) , 853
Iatrogenic foreign body in urinary bladder: Holmium laser vs. Ceramic, and the winner is…
Available at: http://www.intbrazjurol.com.br/video-section/20180229_Castellani_et_al
- 1 August 2019
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 45 (4) , 853
Open AccessIatrogenic foreign body in urinary bladder: Holmium laser vs. Ceramic, and the winner is…
Available at: http://www.intbrazjurol.com.br/video-section/20180229_Castellani_et_al
- 1 March 2019
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 8 (S1) , S119-S120
Re: challenging the dogma of simultaneous resection of bladder tumor and benign prostate
Re: challenging the dogma of simultaneous resection of bladder tumor and benign prostate
- 1 March 2019
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 8 (S1) , S119-S120
Re: challenging the dogma of simultaneous resection of bladder tumor and benign prostate
Re: challenging the dogma of simultaneous resection of bladder tumor and benign prostate